The QualityStocks Daily Thursday, December 13th, 2018

Today's Top 3 StockMarketWatch

Small Cap Firm (ADIL) +104.93%

QualityStocks (SENZ) +96.15%

TopPennyStockMovers (INLB) +20.37%

The QualityStocks Daily Stock List

Medifocus, Inc. (MDFZF)

SmallCapVoice, Investor Place, Investor Network, Barchart, Street Insider, FinancialContent, TradingView, MoneyHub, OTC Markets, MarketWatch, Otc.Watch, and Wallet Investor reported previously on Medifocus, Inc. (MDFZF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Medifocus, Inc. has a portfolio of medical technologies that use patented  Focal Thermal Technology  to treat conditions ranging from Prostate Diseases to Breast Cancer. The Company’s portfolio of medical products includes thermotherapy systems for the treatment of Benign Prostatic Hyperplasia (BPH) and breast cancer. Medifocus is headquartered in Columbia, Maryland and the Company lists on the OTC Markets Group’s OTCQB.

Medifocus owns two technology platforms with about 100 issued and pending U.S. and international patents. One platform is the “Endo-thermotherapy Platform”. The other platform is the “Adaptive Phased Array Microwave Focusing Platform”. Based on these proprietary technology platforms, Medifocus has developed two advanced therapeutic products. One is the Prolieve® system for the treatment of BPH. The other is the Adaptive Phased Array (APA)-1000 system for the treatment of breast cancer.

The Prolieve® Thermodilatation™ System provides symptomatic relief to men with Benign Prostatic Hyperplasia (BPH) by way of a simple, 45-minute, in-office treatment. Prolieve® is Food and Drug Administration (FDA) and Medicare approved for treating symptomatic BPH with greater than 100,000 cases performed in the United States alone, and with proven long-term safety, efficacy, and durability. The purpose of the Prolieve system is to provide a relatively painless and effective alternative to drug therapy, as well as certain kinds of surgical procedures to treat the symptoms of BPH.

The Company’s Heat Activated Gene Therapy, exclusively licensed from Duke University, aims at utilizing Medifocus’ Focal Thermal Technology to enhance selective expression of therapeutic genes injected intratumorally to optimize cancer cell killing while reducing systemic side effects.

The APA 1000 Breast Cancer Treatment System developed by the Massachusetts Institute of Technology (MIT) has been shown in Phase 2 clinical trials to offer considerable additional shrinkage of the sizes of breast cancer in combined ChemoThermal therapy in comparison to Chemotherapy alone. Furthermore, it was shown to be effective in decreasing margin positivity when patients were treated with APA 1000 prior to lumpectomy.

Last month, Medifocus reported a 26 percent increase in Revenue for the quarter ended September 30, 2018, and a 14 percent increase for the six months ending September 30, 2018, versus the same periods in 2017. Prolieve® Sales were $704,195 for the quarter ended September 30, 2018, versus $557,600 for the same period the year prior. For the six months ended September 30, 2018, Sales increased to $1,441,585 from $1,266,500 for the same period in 2017.

Last week, Medifocus announced that on November 21, 2018, the FDA approved a PMA (Post Market Approval) Supplement for new labeling based on the results of the Company’s Post Approval Study (PAS).

Dr. William Jow, Medifocus President and Chief Executive Officer stated, “The successful completion of the 5 year follow-up FDA PAS and the approval of the PMA Supplement labeling are significant milestones and achievements to enable Medifocus to rebrand Prolieve® as the only FDA approved Transurethral ThermoDilatation™ Microwave Therapy (TUTD™) BPH treatment system with proven excellent short-term and long-term clinical benefits.”

Medifocus, Inc. (MDFZF), closed Thursday's trading session at $0.0236, even for the day. The average volume for the last 3 months is 16,193 and the stock's 52-week low/high is $0.006/$0.0514.

chart

RedHawk Holdings Corp. (IDNG)

TopPennyStockMovers, Real Pennies, Greenbackers, Fast Money Alerts, Mad Money Picks, The Observer, Innovative Marketing, Penny Stock General, Stock Shock and Awe, PennyStocks24, and Hot Stock Profits reported earlier on RedHawk Holdings Corp. (IDNG), and we also report on the Company, here at the QualityStocks Daily Newsletter.

RedHawk Holdings Corp. is a diversified holding company listed on the OTC Markets. The Company, via its subsidiaries, engages in the sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. RedHawk Holdings was formerly Independence Energy Corp. RedHawk’s subsidiaries are RedHawk Medical, EcoGen Europe, RedHawk Energy Corp., and RedHawk Land & Hospitality. RedHawk Holdings is based in Louisiana.

RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System. This System is a unique, closed cabinet, nominal dose transmission full body x-ray scanner.

Through its RedHawk Medical Products business unit, RedHawk Holdings sells WoundClot Surgical - Advanced Bleeding Control; the Sharps and Needle Destruction Device (SANDD™); the Carotid Artery Digital Non-Contact Thermometer, and Zonis®.  

RedHawk Medical Products UK Limited is a specialist medical device company. It delivers innovative product solutions to healthcare markets in the United Kingdom (UK), Europe and the Middle East.

EcoGen Europe’s dedication is to healthcare and the NHS. Its commitment is to securing savings across the drug budget in primary care. This is while providing innovation to drive patient care in the acute setting. Last month, RedHawk Holdings announced that it recently completed its financial and legal due diligence and upon execution of final agreements, it will increase its ownership interest in EcoGen Europe to 75 percent.

RedHawk’s financial services revenue is from brokerage services earned in association with debt placement services and investments in oil and gas exploration and production. The Company’s real estate leasing revenues come from varied commercial properties under long-term lease. Moreover, its real estate investment unit holds limited liability company interest in different commercial restoration projects in Hawaii.

EcoGen Europe has signed an exclusive agreement to license and supply a new non-patent infringing generic spray formulation of Sildenafil Citrate in the UK. EcoGen will market the new spray under the brand name Azulvig. EcoGen expects to start marketing Azulvig after receipt of final UK regulatory approval.

RedHawk Holdings has acquired a stake in Tigress Energy Partners. RedHawk agreed to acquire up to a 25 percent interest in Marlin USA Energy Partners, LLC, the minority owner of Tigress Energy Partners, LLC (TEP). The majority ownership of TEP is held by Tigress Holdings, LLC, a limited liability company majority-owned by Cynthia DiBartolo, Chief Executive Officer of Tigress Financial Partners LLC (TFP).

RedHawk Holdings has also completed the re-engineering of its Sharps and Needle Destruction Device (SANDD). It received pre-market clearance from the U.S. Food and Drug Administration (FDA) for the sale of SANDD in the U.S.  RedHawk Medical Products acquired the tangible and intangible property rights to SANDD (formerly known as the Disintegrator™ Insulin Needle Destruction Unit) in December 2015.

In early August, RedHawk Holdings announced that its wholly-owned real estate subsidiary, RedHawk Land & Hospitality LLC, entered into new agreements for the lease of its two commercial properties in Lafayette, Louisiana. The Company said it entered into a new triple-net lease agreement with the Louisiana 3rd Circuit Court of Appeal to renew and extend the present lease term to December 31, 2022. The new lease agreement was effective August 1, 2017 and included certain rate increases.

RedHawk Holdings Corp. (IDNG), closed Thursday's trading session at $0.0012, up 50.00%, on 5,029,514 volume with 22 trades. The average volume for the last 3 months is 2,656,344 and the stock's 52-week low/high is $0.0008/$0.009.

chart

Pharma-Bio Serv, Inc. (PBSV)

Zacks, Capital Cube, Marketwired, Wallet Investor, Morningstar, YCharts, GuruFocus, Market Screener, Barchart, Stockopedia, Dividend Investor, Business Wire, Stockhouse, MarketWatch, InvestorsHub, and Marketbeat reported earlier  on Pharma-Bio Serv, Inc. (PBSV), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Pharma-Bio Serv, Inc. is a compliance, project management, and technology transfer support consulting firm. Its chief business is Food and Drug Administration (FDA) and other international regulatory compliance agency related services, with integrated portfolio services including microbiological and chemical testing services. This includes microbiological and chemical testing services for clients in the Pharmaceutical, Biotechnology, and Chemical, Medical Device, Cosmetic, Food and Allied Products industries, at its laboratory testing facility in Puerto Rico. OTCQB-listed, Pharma-Bio Serv is headquartered in Dorado, Puerto Rico. The Company also has operations in the U.S.,  Ireland, and Spain.

Pharma-Bio Serv supports its clients through the product lifecycle. This includes research and development  (R&D)  Studies; NDA Documentation and Filings; PAI Readiness; Audit & Inspection Preparation, Management and Response, and Post Approval. Moreover, this includes Quality Systems; Technology Transfer; Validation, and Manufacturing Controls & Process Support. The Company’s services also include "Pharma Serv Academy." This division provides technical and regulatory standards seminars/training conducted by industry experts.

  The Company’s divisions include Scienza Labs, the aforementioned PharmaServ Academy, and Metrologix. Scienza Labs provides microbiological and analytical testing, field support, method development, as well as validation. Metrologix provides laboratory and on-site calibration services, calibration program management, risk management, compliance remediation, and instrument rental.

This past October, Pharma-Bio Serv announced that its Board of Directors declared a cash dividend of $0.075 per share. The Company’s Board will continue to evaluate Pharma-Bio Serv’s strategic plan that might include future acquisitions, sales of business units, dividends or any combination of these opportunities while continuing its stock repurchase plan.

In September of this year, the Company announced it completed the sale of substantially all of the assets of its laboratory business to Romark Global Pharma, LLC for $5 million.

Mr. Victor Sanchez, Pharma-Bio Serv Chief Executive Officer said in September, "With the completion of the sale, we move forward with our strategy to concentrate our focus and efforts on our core consulting business, and streamline our operating segments."

Pharma-Bio Serv, Inc. (PBSV), closed Thursday's trading session at $1.14, even for the day. The average volume for the last 3 months is 11,077 and the stock's 52-week low/high is $0.432/$1.25.

chart

Indoor Harvest Corp. (INQD)

Orbit Stocks, SmallCapVoice,  Fast Money Alerts, Stock Shock and Awe, OTPicks, Penny Stock General,  CFN Media Group, Cannabis Financial Network News, MassiveStockProfits, and PennyPickAlerts reported previously on Indoor Harvest Corp. (INQD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Indoor Harvest  Corp. is a developer of personalized cannabis medicines. It is also a provider of advanced cultivation technology, methods, and processes. The Company provides the cannabis industry production platforms for Building Integrated Agriculture (BIA) production. Indoor Harvest is based in Houston, Texas. Established in 2011, the Company lists on the OTC Markets’ OTCQB. 

On August 4, 2017, Indoor Harvest entered into an Agreement and Plan of Merger with Alamo CBD. The Company has transitioned into a producer of cannabis for research and pharmaceutical development. Its patent pending aeroponic methods allow for the production of chemically consistent, contaminate free cannabis, economically at scale.

Indoor Harvest’s plan is to develop facilities in the States of Arizona and Colorado. It is looking to use the relationships and technology it has developed to become a registered producer and seller under the federal Controlled Substance Act (CSA) of pharmaceutical grade cannabis for research by third parties developing targeted treatment for specific medical symptoms. Indoor Harvest’s plan is to generate revenue from its developed facilities through leasing and licensing of its technology and methods.

Indoor Harvest and Zoned Properties, Inc. announced in October of 2017 that the two companies entered into a Binding Letter of Intent (LOI) outlining three independent agreements to complete research and development (R&D) projects for licensed medical marijuana facilities to be located in Tempe, Arizona; Parachute, Colorado; and Stockdale, Texas, or other location to be determined after approval of a provisional license under the Texas Compassionate Use program. Zoned Properties is a strategic real estate development enterprise.

Indoor Harvest completed initial conceptual design and engineering work during Q1 2018 to integrate its HPA technology with HVAC systems with its partner Harvest Air, LLC. Furthermore, the Company entered into discussions with cannabis producers in the United States and Canada to use its technology and methods.

On December 3, 2018, Indoor Harvest entered into a consulting agreement with Mr. Daniel Strachman. Mr. Strachman will assist Indoor Harvest’s Chief Executive Officer with financial planning, evaluation of third-party engagements, merger and acquisition due diligence, business development, and engagement with stakeholders. The Consulting Agreement started on the Effective Date (December 3, 2018) for an initial term of three months. Indoor Harvest and Mr. Strachman plan on entering into a further agreement prior to the expiration of the Initial Term.

Indoor Harvest Corp. (INQD), closed Thursday's trading session at $0.0555, up 2.78%, on 117,671 volume with 22 trades. The average volume for the last 3 months is 323,914 and the stock's 52-week low/high is $0.05/$0.449.

chart

Sprott, Inc. (SPOXF)

Penny Stock Tweets, Stock Digest, Market Screener, Interactive Brokers, Tip Ranks, Capital Cube, StreetInsider, Stockhouse, InvestorsHub, Stock Gumshoe, Stockwatch, 4-Traders, The Street, TradingView, and the Dividend Channel reported previously on Sprott, Inc. (SPOXF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Sprott, Inc. provides investors with access to highly-differentiated precious metals and real assets investment strategies. Its best-in-class investment products include unique physical bullion trusts, mining ETFs (Exchange-Traded Funds), as well as private equity and debt strategies. A global asset manager, Sprott is headquartered in Toronto, Ontario. The Company also has offices in Connecticut, Carlsbad, California, and Vancouver, British Columbia.

Sprott’s capabilities enable it to provide flexible financing solutions across the mining life cycle. Moreover, capabilities allow it to match global investor demand with a robust pipeline of investment opportunities. By way of its subsidiaries, Sprott provides asset management, portfolio management, wealth management, fund management, and administrative and consulting services to its clients. The Company offers mutual funds, hedge funds, and offshore funds, along with managed accounts. Sprott also provides broker-dealer activities.

Additionally, Sprott partners with natural resource companies to meet their capital requirements through its merchant banking and resource lending activities. The Company was formed in 1981 by Mr. Eric Sprott, an early champion of precious metals and real assets investing. Today, Sprott serves greater than 200,000 international clients. In addition, the Company has more than C$11.5 billion in assets under management after the acquisition of Central Fund of Canada Limited.

Regarding Asset Management, Sprott offers Sprott Physical Bullion Trusts, Sprott ETFs, and Actively-Managed Strategies. Concerning Resource Financing, the Company has its Sprott Resource Lending, Sprott Capital Partners, as well as Sprott Resource Holdings. Concerning Wealth Management, Sprott provides wealth management services to U.S., Canadian, and worldwide clients via its subsidiaries - Sprott US and Sprott Private Wealth.

Last month, Sprott announced its financial results for the three months ended September 30, 2018. Total Net Revenues were $15.4 million, reflecting a decrease of $31.7 million (67 percent) from the quarter ended September 30, 2017. The prior year’s Net Revenues contained $33.8 million of proceeds from the sale of the Company’s non-core diversified assets.

Net Income was $2.0 million ($0.01 per share). This reflects a decrease of $27.8 million from the quarter ended September 30, 2017. The prior year’s Net Income contained the proceeds from the sale of Sprott’s non-core diversified assets and also the Company’s earnings generation for one month of that quarter.

Mr. Peter Grosskopf, Sprott Chief Executive Officer, said, "Despite a pullback in precious metal prices, we reported $9.7 million of adjusted base EBITDA during the quarter, an increase of more than 21 percent from the third quarter of 2017 and consistent with the approximate $10 million per quarter we have been generating in 2018. We are focused on delivering profitable growth and expect to significantly increase the scale of our private lending business before the end of 2018. We are also exploring new product launches in our exchange-listed products business."

Sprott, Inc. (SPOXF), closed Thursday's trading session at $1.92, down 1.54%, on 244,726 volume with 219 trades. The average volume for the last 3 months is 270,695 and the stock's 52-week low/high is $1.71/$3.29.

chart

Novo Resources Corp. (NSRPF)

The Online Investor, Insider Financial, Metals News, OTC Markets, Streetwise Reports, 4-Traders, StockInvest, Mining Stock Valuator, Energy and Gold, The OTC Reporter, Spotlight Growth, YCharts, Emerging Growth, Dividend Investor, Capital Cube, Investors Hangout, GuruFocus, Junior Mining Network, Stockhouse, InvestorsHub, Finance Registrar, TradingView, and MarketWatch reported previously on Novo Resources Corp. (NSRPF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Novo Resources Corp.’s focus is to evaluate, acquire, and explore gold properties. At present, the Company’s emphasis is to explore and develop gold projects in the Pilbara area of Western Australia. Novo has built up a substantial land package encompassing about 12,000 sq km. OTCQX-listed, Novo Resources is headquartered in Vancouver, British Columbia.

Novo also controls a 100 percent interest in roughly 2 sq kms covering much of the Tuscarora Au-Ag vein district in Nevada. The Company’s current focus is its Beatons Creek and Marble Bar paleoplacer gold projects in Western Australia. Novo owns the approximately 10 sq km Beatons Creek Tenements in Western Australia. Comprehensive test work conducted on Beatons Creek conglomerates indicates high gravity recoveries.

The Company has the right to earn a 70 perccent interest in the approximately 1,800 sq km Pilbara Paleoplacer Gold Project that includes the Beatons Creek and Marble Bar paleoplacer gold projects, in Western Australia from the Creasy Group. Moreover, Novo Resources has acquired, through staking, a 100 percent interest in roughly 6,021 sq kms of mineral rights in the Karratha area. It staked exploration applications encompassing around 7,000 sq kms in the area around Karratha. Novo controls an additional 2,000 sq kms (approximately) elsewhere in the Pilbara area.

Pertaining to the Karratha Gold Project, Novo Resources entered into farm-in and joint venture (JV) agreements with Artemis Resources to earn-in on an additional 1,256 sq kms of mineral rights. In addition, the Company entered into an option agreement for 100 percent of Welcome Exploration’s gold rights. Also, Novo entered into sale and purchase agreements and farm-in and JV agreements for an 80 percent interest in the Comet Well property.

Today, Novo Resources provided an update of exploration activities and short-term goals at a number of its Pilbara gold projects. Regarding Egina, the Company’s preliminary bulk sampling program at Egina is nearing completion. A roughly 170 tonne bulk sample was recently excavated. It is undergoing processing employing Novo’s IGR3000 gravity gold plant. Initial results are expected by the end of December.

Concerning Karratha, assays of concentrates from recent mechanical sorting tests are expected back by the end of this month. Regarding Beatons Creek, a set of 58 bulk samples, each weighing about two tonnes, was collected from gold-bearing conglomerates across the Beatons Creek project during 2018. Analyses from these samples are anticipated to return by February 2019.

Furthermore, Talga Talga is one of Novo Resources’ East Pilbara assets. It is around 110 km north of Beatons Creek. Recent spot rock chip sampling of veins returned highly encouraging assay results. This includes grades of 81.4 g/t, 46.9 g/t, 35.1 g/t and 30.0 g/t gold. However, these grades are not necessarily representative of mineralization at Talga Talga. Of 149 samples, 68 returned grades greater than 0.5 g/t gold and 33 returned grades greater than 5.0 g/t gold.

Novo Resources Corp. (NSRPF), closed Thursday's trading session at $1.488, down 3.38%, on 82,809 volume with 118 trades. The average volume for the last 3 months is 136,912 and the stock's 52-week low/high is $1.42/$5.00.

chart

Reliq Health Technologies, Inc. (RQHTF)

Stockhouse, Business Insider, Barchart, Investors Hangout, Penny Stock Tweets, Capital Cube, Emerging Growth, Morningstar, MarketWatch, Streetwise Reports, InvestorsHub, Barron’s, OTC Markets, GuruFocus, Zacks, Financial Post, Equities.com, and StockInvest.us reported on Reliq Health Technologies, Inc. (RQHTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Reliq Health Technologies, Inc. is a technology company focused on creating innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare. The Company’s robust iUGO Care platform supports care coordination and community-based healthcare. The Company formerly went by the name Moseda Technologies, Inc. It changed its name to Reliq Health Technologies, Inc. in May 2016. Reliq Health Technologies is based in Vancouver, British Columbia.

The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. Reliq Health Technologies’ platform provides automated remote patient monitoring in the home. It supports secure communication between all members of the patient’s circle of care. The Company has developed a novel SaaS (Software-as-a-Service) solution for the Community Healthcare market.

The iUGO Care platform turns the patient’s home into a “virtual hospital ward” utilizing an automated two-way voice, proximity sensors, as well as biometric monitoring devices. Data collected in the home is automatically uploaded to the iUGO Care secure cloud. There, it is available to all members of the patient’s circle of care, with automated alerts if a patient’s condition begins to deteriorate. The iUGO Care platform improves medication adherence.

In April, Reliq Health Technologies announced the expansion of its contract with Paz Home Health LLC in Texas to provide its iUGO Care remote patient monitoring and telemedicine solution. The revised contract increases the number of Paz Home Health subscribers by 5,000 patients. This brings the total to more than 15,000 patients. This will generate greater than $9 Million USD in annual recurring revenue at full deployment, by Q4 2018.

Last week, Reliq Health Technologies announced that it signed a Memorandum of Understanding (MOU) with ForaCare, Inc. of Moorpark, California, to address hardware availability for iUGO Care customers. ForaCare is a technology company. Its commitment is to the design, development, and marketing of unique medical device products for chronic disease management.

Dr. Lisa Crossley, Reliq Health Technologies’ Chief Executive Officer, said, “We are very pleased to have partnered with ForaCare Inc. to help our customers provide their remote and rural patients with cellular-enabled monitoring devices. Reliq’s iUGO Care platform is hardware-agnostic, meaning that our clients can choose whichever monitoring devices they feel will work best for their patients.”

Reliq Health Technologies, Inc. (RQHTF), closed Thursday's trading session at $0.2042, up 3.87%, on 8,150 volume with 4 trades. The average volume for the last 3 months is 70,198 and the stock's 52-week low/high is $0.175/$2.03.

chart

Teranga Gold Corporation (TGCDF)

Capital Equity Review, The Street, Stockhouse, OTC Markets, 4-Traders, StreetInsider, InvestorsHub, The Northern Miner, Simply Wall St, and 24hgold reported on Teranga Gold Corporation (TGCDF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Teranga Gold Corporation is a multi-jurisdictional West African gold company. Its emphasis is on production and development and the exploration of over 6,400 km2 of land located on prospective gold belts. The Company is advancing its Wahgnion Gold Project, with a recently released positive feasibility study (FS), and conducting extensive exploration programs in Burkina Faso, Senegal and Côte d’Ivoire. OTCQB-listed, Teranga Gold is headquartered in Toronto, Ontario.

The Company has close to 4.0 million ounces of gold reserves from its combined Sabodala Gold operations and Wahgnion Gold Project. Since its initial public offering (IPO) in 2010, Teranga Gold has produced greater than 1.4 million ounces of gold from its operations in Senegal, which as of June 30, 2017 had a reserve base of 2.7 million ounces of gold.

The Sabodala Gold mine is the only gold mine and mill in Senegal, West Africa.  It is roughly 650km southeast of Dakar, the capital of Senegal. Sabodala has been in operation since 2009.

Teranga owns and operates the Sabodala Gold mine. The Sabodala Mining Concession and the surrounding exploration permits are situated within the highly prospective Kedougou-Kenieba Inlier that forms part of the Paleoproterozoic age Birimian Terrane of the West African Craton. Mining of the Sabodala open pit is carried out by owner-operated conventional truck and shovel open pit mining.

The Banfora Gold Project was acquired in October of 2016 as part of Teranga Gold’s acquisition of ASX-listed Gryphon Minerals. The fully permitted, high-grade, open pit Banfora Gold Project is in the south-west of Burkina Faso, West Africa in a major gold producing district host to a number of world class gold deposits. Teranga Gold owns 90 percent of the Project. The Burkina Faso government owns the remaining 10 percent.

In April, Teranga Gold announced that its phase 2 diamond drill program at the C-Zone prospect on the Golden Hill property in Burkina Faso, West Africa returned near surface and deeper high-grade gold intersections. Teranga Gold has an earn-in agreement on Golden Hill with Boss Resources Limited. Teranga, as operator, can earn an 80 percent interest in the joint venture (JV) upon delivery of a feasibility study (FS) and the payment of AUD2.5 million.

The Golden Hill property consists of three adjacent exploration permits encompassing 470 km2 situated in southwest Burkina Faso in the central part of the Houndé Greenstone Belt. The belt hosts several high-grade gold discoveries.

Last week, Teranga Gold reported its financial and operating results for the three months ended March 31, 2018.

Mr. Richard Young, Teranga Gold’s President and Chief Executive Officer, said, “We have a clear vision for Teranga and that is to become a multi-asset, mid-tier gold producer in West Africa. With the financings now in place to build our second mine and to move a third project through a future feasibility study, we have a well-defined roadmap for executing on our vision.  Beyond the near-term priorities of Wahgnion and Golden Hill, we are also focused on advancing our extensive organic pipeline in Côte d’Ivoire for future growth.”

Teranga Gold Corporation (TGCDF), closed Thursday's trading session at $2.8196, up 2.53%, on 244,726 volume with 15 trades. The average volume for the last 3 months is 270,695 and the stock's 52-week low/high is $1.83/$4.32.

chart

Bannerman Resources Limited (BNNLF)

Penny Stock Tweets, MarketWatch, Wallmine, Morningstar, Northern Miner, Capital Cube, Wallet Investor, HotStocked, 4-Traders, MoneyHub, Speculating Stocks, Research and Markets, Streetwise Reports, Stockhouse, The Stock Market Watch, Barchart, and Ventureline reported earlier on Bannerman Resources Limited (BNNLF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Bannerman Resources Limited is an exploration and development company with a 95 percent interest in the Etango Uranium Project in Namibia. The Company is a member of the Namibian Uranium Association, Namibian Chamber of Mines and the Australia-Africa Minerals % Energy Group (AAMEG). Bannerman Resources has its corporate office in Perth, Western Australia. The Etango project office is in Swakopmund, Namibia. Bannerman lists on the OTC Markets.

The Etango Uranium Project is one of the world’s largest undeveloped uranium projects. It is one of the few uranium projects worldwide with a completed Definitive Feasibility Study (DFS) and environmental permitting. A two year pilot supports the DFS. The Etango Uranium Project will be a top 10 producer upon development.

The Etango license area is approximately 500 square kms. The Project is considered by Bannerman Resources to be a low technical and environmental risk project, with conventional open pit mining and sulphuric acid heap leaching at 20 million tonnes per annum.

The Etango Uranium Project is situated on the flat Namib Desert sands, roughly 38 kilometers (by road) east of the coastal town of Swakopmund. The Project is well located for external infrastructure requirements.

Based on the DFS, production is anticipated to be 7-9 million pounds U3O8 per annum for the first five years and 6-8 million pounds U3O8 per annum subsequently. Etango will have a minimum mine life of 16 years with considerable expansion potential via the conversion of existing Inferred Resource and the deposit being open at depth and along strike.

A heap leach demonstration plant has technically de-risked the Etango Uranium Project. Etango has first-rate leaching dynamics, low acid consumption, as well as no impurities or clays. There exist large satellite deposits close by. In addition, Etango is the largest uranium development project or mine not presently owned by an international uranium major or state owned entity (SOE).

Bannerman Resources Limited (BNNLF), closed Thursday's trading session at $0.0301, down 2.90%, on 7,000 volume with 2 trades. The average volume for the last 3 months is 57,795 and the stock's 52-week low/high is $0.025/$0.061.

chart

ProMIS Neurosciences, Inc. (ARFXF)

Streetwise Reports and OTC Markets reported on ProMIS Neurosciences, Inc. (ARFXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A development stage biotechnology enterprise, ProMIS Neurosciences, Inc. concentrates on discovering and developing precision medicine therapeutics to treat neurodegenerative diseases, in particular Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS). ProMIS Neurosciences has offices in Toronto, Ontario and Cambridge, Massachusetts. The Company’s shares trade on the OTC Markets Group’s OTCQB.

ProMIS Neurosciences’ proprietary target discovery engine is founded on the use of two complementary techniques. ProMIS applies its thermodynamic, computational discovery platform-ProMIS™and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins. Utilizing this innovative precision medicine approach, the Company is developing novel antibody therapeutics and specific companion diagnostics for AD and ALS.

The Company’s lead programs are following a “best in class” strategy targeting Amyloid beta in Alzheimer’s disease, with advantages over ”first in class” therapy from Biogen (aducanumab). ProMIS uses its proprietary technology platform to create highly selective antibodies.

ProMIS Neurosciences’ lead product is PMN310 in Alzheimer’s disease. It is on course to further confirm differentiation from likely “first in class” Biogen’s aducanumab. In addition, it is on course to initiate clinical trials in 2019 and potentially superior clinical data in comparison to aducanumab in late 2021 shortly after aducanumab anticipated approval.

For Alzheimer’s disease, ProMIS Neurosciences’ most advanced priority program, three validated product candidates have been designated. These are PMN310, PMN350, and PMN330.

Earlier this month, ProMIS Neurosciences announced that its lead product candidate for Alzheimer's disease (AD), PMN310, showed absence of binding to amyloid beta (Aβ) plaque in and around blood vessels in AD brain samples in a preclinical study directly comparing PMN310 to other Aβ-directed antibodies.

Binding of therapeutic antibodies to Aβ deposits in brain tissue, more specifically blood vessels, is believed to underlie the development of ARIA (amyloid-related imaging abnormalities; brain swelling and microhemorrhages) in treated AD patients.

ProMIS Neurosciences’ President and Chief Executive Officer, Mr. Elliot Goldstein, MD, stated: "PMN310 was designed to selectively target the toxic, prion-like Aβ oligomers, now widely believed to be a root cause of AD. By not targeting Aβ plaque, especially in and around blood vessels in the brain, we anticipate PMN310 may not be associated with the dose-limiting brain swelling seen with plaque-binding antibody therapeutics like aducanumab. Confirmation of such an improved safety profile in clinical trials would allow for administration of higher doses to AD patients, thereby leading to greater therapeutic potency of PMN310."  

 

ProMIS Neurosciences, Inc. (ARFXF), closed Thursday's trading session at $0.1572, up 4.04%, on 72,000 volume with 23 trades. The average volume for the last 3 months is 84,101 and the stock's 52-week low/high is $0.138/$0.699.

chart

Sport Endurance, Inc. (SENZ)

Stock Traders Chat, CoolPennyStocks, Promotion Stock Secrets, Stock Beast, StockRockandRoll, Open Water Investments, OTC Picks, Penny Invest, Stock Rich, StockEgg, StockMister, 24-7 Stock Alert, HotOTC, Simply Best Penny Stocks, Top Best Pennystocks, BullRally, Global Equity Report, and Penny Stock Explosion reported earlier on Sport Endurance, Inc. (SENZ), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Sport Endurance, Inc. develops, markets, and distributes nutritional supplement products throughout the United States. The Company’s objective is to improve health through providing quality and effective nutritional supplements. All Sport Endurance brand products are manufactured in the U.S. in Food and Drug Administration (FDA)-inspected facilities with strict quality control that follows Good Manufacturing Practices (GMP). Sport Endurance is headquartered in Jersey City, New Jersey.

Sport Endurance has also created a cryptocurrency lending subsidiary. Yield Endurance is the Company’s newly established cryptocurrency lending subsidiary that offers institutional investors a lending program for their cryptocurrency assets.

Via its wholly-owned subsidiary, Yield Endurance, and its strategic agreement with Madison Partners, the Company is focused on increasing liquidity and institutional participation in the cryptocurrency markets through providing institutional investors, through Madison Partners, the ability to borrow, hedge, and arbitrage cryptocurrencies that trade on the different cryptocurrency exchanges. This includes Bitcoin, Bitcoin Cash, Ethereum and Litecoin.

Pertaining to nutritional supplement products, Sport Endurance’s principal focus is on three areas of health that most directly affect the lives of many active adults. These are Total Wellness, Performance, and Recovery. Sport Endurance has launched its web portal to market men’s health products direct to consumers.

Sport Endurance’s supplements are natural supplements and contain no ingredients that would require a prescription. The all-natural dietary supplements meet wellness needs without using harsh synthetic chemicals.

Earlier this month, Sport Endurance’s wholly-owned subsidiary, Yield Endurance, announced that its strategic business partner, Madison Partners LLC, extended an initial loan of 110 Bitcoins under the Confidential BTC Lending Program Participation Agreement between Madison Partners and the Subsidiary.

The Subsidiary entered into a strategic partnership and confidential BTC Lending Program Participation Agreement with Madison Partners, through which the Subsidiary made available $5 million of bitcoins to Madison Partners for lending.

The initial loan, in the amount of 110 bitcoins or about $1.03 million (based on the closing price of bitcoin as of April 30, 2018 according to Coindesk) was lent by Madison Partners to an institutional investor from the initial bitcoin made available to Madison from the Subsidiary. Madison Partners is a registered Money Services Business. Its emphasis is on providing counter parties with over the counter liquidity and block trading services.

Sport Endurance, Inc. (SENZ), closed Thursday's trading session at $0.51, up 95.15%, on 25,635 volume with 15 trades. The average volume for the last 3 months is 953 and the stock's 52-week low/high is $0.10/$1.20.

chart

ProBility Media Corporation (PBYA)

NetworkNewsWire.com, MarketWatch, Morningstar, Marketwired, Barchart, The Street, OTC Markets, InvestorsHub, Simply Wall St, and Stocks to Buy Now reported on ProBility Media Corporation (PBYA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

ProBility Media Corporation is a technology business offering immersive technologies, digital learning and compliance solutions for the education and training markets. An education technology (EdTech) company, it serves customers from the individual to the small business to the enterprise level corporation. ProBility Media is based in Houston, Texas, with offices in Florida, New York, and Vermont.

ProBility Media offers premier training courses and materials and works to prepare the workforce for excellence. ProBility Media is executing the strategy of defragmenting the marketplace of thousands of disparate companies through acquiring smaller companies in the areas of its expertise and organically building revenue through synergies.

ProBility Media is looking for acquisition targets that service engineering firms, electrical contractors, fabricators, plumbing contractors, pipe fitters, riggers, and qc firms and additional vocational industries.

ProBility Media, through its electrical training division, is becoming the largest wholesaler of electrical codes and exam prep material in the United States. In addition, by way of its construction training division, the Company offers programs in 22 states. This division serves one of the largest certification markets in the U.S.

ProBility Media announced in December of 2017 the execution of a binding Letter of Intent (LOI) to acquire North American Crane Bureau Group, Inc. (NACB). NACB’s mission is to provide the most comprehensive safety training courses, materials, and certifications for operators, inspectors, and trainers within the crane and lifting industries in the United States. and internationally. NACB is based in Lake Mary, Florida.

Disco Learning Media, a division of ProBility Media, unveiled the new Watt Watchers 2.0 energy education program at the Texas Energy Managers Association (TEMA) Conference on April 25, 2018 in New Braunfels, Texas.

The launch of the new program followed a keynote address by author and Principal Investigator, Dr. Michael E. Webber, an Advisory Board Member of ProBility Media. The original Watt Watchers program is undergoing modernization by Disco Learning Media and Dr. Webber to reflect current energy and environmental topics.

This week, ProBility Media announced that North American Crane Bureau is launching its new technologically advanced product for crane training using the latest advancements in virtual reality. The Company is offering product demonstrations at The Association for Iron & Steel Technology AISTECH 2018 conference in Philadelphia from May 7-10, 2018.

ProBility Media Corporation (PBYA), closed Thursday's trading session at $0.0004, even for the day, on 20,748,671 volume with 31 trades. The average volume for the last 3 months is 7,099,020 and the stock's 52-week low/high is $0.0003/$0.3065.

chart

Wealthcraft Capital, Inc. (WCCP)

OTC Markets, MarketWatch, InvestorsHub, 4-Traders, Stockhouse, Simply Wall St, WalletInvestor, Penny Stock Hub, Penny Stock Tweets, Barchart, Stock Target Advisor, InvestorPlace, and Silicon Investor reported on Wealthcraft Capital, Inc. (WCCP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Wealthcraft Capital, Inc. concentrates on the investment of capital in private companies, which are interested in expanding their business through gaining better access to capital, management consulting, as well as business development. Mr. Adam D. Sexton is the President and Chief Executive Officer (CEO) of the Company.

Mr. Sexton is an experienced business, entertainment, and digital media leader. He has wide-ranging experience launching and operating disruptive digital products and services for worldwide entertainment, technology industry leaders, as well as start-ups.

Wealthcraft Capital was previously known as Wealthcraft Systems, Inc. It changed its name to Wealthcraft Capital, Inc. in February of 2017. The Company’s shares trade on the OTC Markets Group’s OTCQB. Wealthcraft Capital has its corporate headquarters in Los Angeles, California.

Last week, WealthCraft Capital announced the acquisition of a majority interest in Geaux Industries in exchange for $1,000,000 of the Company’s common stock at market value. Geaux Industries is a provider of security services for commercial, retail and industrial customers, with customized services and special patrol methods applicable for the cannabis industry, 

Geaux Industries is licensed by the California Department of Consumer Affairs. For selected security operations, Geaux does business under the franchised name of Signal 88 Security. The exchange agreement provides for Wealthcraft Capital to acquire the minority interest, under certain terms and conditions.

Mr. Sexton said, “With the legalization of recreational cannabis in California on January 1, 2018, the Company believes that there is a significant market opportunity for Geaux Industries to be one of the leading providers of specialized security services.”

Geaux Industries will continue to address the market with inventive new technologies and services and creative business models for the traditional and non-traditional businesses.

At the closing, Wealthcraft Capital CEO, Adam Sexton, was appointed to fill a vacancy on the Board of Directors of Geaux Industries.

Wealthcraft Capital, Inc. (WCCP), closed Thursday's trading session at $0.26, up 3.17%, on 21,331 volume with 6 trades. The average volume for the last 3 months is 2,891 and the stock's 52-week low/high is $0.04/$0.85.

chart

PUDO, Inc. (PDPTF)

Penny Stock Tweets, Stockreads, Penny Stock Hub, GuruFocus, Investorx, The Wall Street Analyzer, Stockwatch, Capital Cube, MarketWatch, Infront Analytics, YCharts, The Street, InvestorsHub, Market Screener, Stockhouse, Morningstar, Wallet Investor, Barchart, Otc.watch, 4-Traders, and Financial Content reported on PUDO, Inc. (PDPTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

PUDO, Inc. is North America's first carrier-neutral Pick-Up Drop-Off Network. The Company is developing North America's only carrier-neutral parcel pick-up/drop-off technology and logistics network, as a way of solving the last-mile parcel-traffic-control gridlock. PUDO formed in 2015. Recently, the Company was named one of the Top 20 most innovative public technology companies by the Canadian Innovation Exchange. OTCQB-listed, PUDO is based in Mississauga, Ontario.

The Company’s team of logistics and parcel traffic management experts have created a market intelligence and trends driven solution. This consists of carrier-neutral plug-and-play technology for desktop and mobile, plus a strategically located network of parcel pick-up and drop-off PUDOpoints for pay-as-you-go use by all players within the e-commerce environment.

A PUDO Point™ is a convenience store typically within minutes of one’s location. It will accept one’s shipments for them and be there when they are ready to pick them up. There are thousands of PUDO-authorized dealer pickup and drop-off locations across the United States and Canada.

PUDO's technology and network virtually eliminates expenses associated with second-attempt deliveries, un-attended parcel theft and spoilage, and mismanaged reverse logistics on returns. The Company’s technology and network provides carriers, retailers, and consumers with needed cost controls, choice, as well as convenience.

Recently, PUDO announced the signing of an Agreement with international third-party logistics company Landmark Global, Inc. (LGI), part of the bpost group, to undertake a mutually beneficial arrangement for LGI and its customers to utilize PUDO's Network of parcel pick-up and drop-off locations, to enhance the last-mile e-commerce parcel delivery experience in Canada on Landmark Global's new Sprintstar network.

Sprintstar drivers can now leave packages at a secure and convenient PUDO location if the delivery recipient is not at home when the driver makes the first delivery attempt. Furthermore, utilizing the PUDO network of services, Landmark Global will be able to expand its Sprintstar service to numerous communities not previously served.

Regarding e-commerce and return logistics, PUDO offers complete and cost-effective return logistics programs for its eRetailers and corporations. The Company has a distributed and remote work force across the United States and Canada.

PUDO, Inc. (PDPTF), closed Thursday's trading session at $0.4486, down 0.40%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 1,061 and the stock's 52-week low/high is $0.288/$2.51.

chart

The QualityStocks Company Corner

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, announced today that its wholly owned subsidiary, CLR Roasters, has accepted an invitation to join Amazon Vendor Central and hired Digital Operative to help grow their brand internationally.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.33, off by 0.47%, on 60,484 volume with 380 trades. The average volume for the last 3 months is 568,453 and the stock's 52-week low/high is $3.167/$16.25.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces successful in vitro analyses of gynecological samples collected using its new Hygee™ medical device. Also today, NetworkNewsWire released a report on the company detailing how ETST’s new genuine CBD/Propovit throat spray formula developed via a strategic partnership with Bionatus is almost market-ready.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.80, up 4.25%, on 65,488 volume with 80 trades. The average volume for the last 3 months is 123,014 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is on a mission to fully explore and identify the lithium production potential at its Irgon Lithium Mine Project. To view the full article, visit: http://nnw.fm/sAw0B.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.2007, up 10.88%, on 180,928 volume with 46 trades. The average volume for the last 3 months is 93,638 and the stock's 52-week low/high is $0.168/$0.971.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today announced its partnership with HelloMD, a leading online cannabis healthcare company. To view the full press release, visit: http://nnw.fm/S5BnY.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.17, off by 3.98%, on 549,826 volume with 677 trades. The average volume for the last 3 months is 1,421,104 and the stock's 52-week low/high is $1.87/$7.89.

Recent News

chart

Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8)

The QualityStocks Daily Newsletter would like to spotlight Kontrol Energy Corp. (CSE: KNR).

NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with Kontrol Energy Corp. (CSE: KNR) (OTC: OTSHF) (FSE: 1K8), a client of NNW and leader in the energy efficiency sector through IOT, Cloud and SaaS technology. The interview can be heard at http://nnw.fm/3HhCe.

Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.

Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.

As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.

Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.

Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.

Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:

  • Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
  • Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
  • Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
  • Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
  • Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.

The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.

The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.

Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.

Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.61, off by 1.61%, on 3,129 volume with 5 trades. The average volume for the last 3 months is 20,360 and the stock's 52-week low/high is $0.46/$1.58.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Targeting the high-end medical and adult-use recreational market, Green Hygienics Holdings Inc. (OTC: GRYN) concentrates on science-driven cannabis cultivation. The company’s growth strategy involves producing revenues from the sales of premium grade cannabis products, developing and licensing valuable intellectual property (IP), making strategic acquisitions and creating trusted global consumer brands. The focus of the Las Vegas, Nevada-based company is pharmaceutical-grade cannabis at higher yields and lower costs.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.3746, off by 6.33%, on 4,100 volume with 2 trades. The average volume for the last 3 months is 14,749 and the stock's 52-week low/high is $0.0175/$0.508.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions, Inc. (OTC: SGSI), a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure and professional service solutions to the service provider (carrier) and corporate enterprise markets, has grown revenues from zero in early 2017 to currently tracking more than $33 million annually, CEO Roger Ponder informed shareholders and investors in a recent 2018 update (http://nnw.fm/4o3YU).

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.23, off by 8.00%, on 22,000 volume with 9 trades. The average volume for the last 3 months is 20,068 and the stock's 52-week low/high is $0.18/$2.59.

Recent News

chart

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that its investee company Refined Resin Technologies Inc. (“Refined Resin”) of Oakland, California, has achieved its California state, Temporary Manufacturing License for Adult and Medicinal Cannabis Products (“Temporary Manufacturing License”). Refined Resin is a cannabinoid research and extraction company that provides B2B products and services to licensed brands, licensed dispensaries and licensed distributors in the medical cannabis supply chain.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.0943, off by 9.06%, on 2,990 volume with 3 trades. The average volume for the last 3 months is 57,219 and the stock's 52-week low/high is $0.084/$0.8736.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint (OTCQB: SING) announced this morning that it looks ahead to provide insight on how the company plans to carry its 2018 momentum forward into 2019. To view the full press release, visit: http://nnw.fm/WO6Pi.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0164, off by 1.80%, on 7,003,442 volume with 198 trades. The average volume for the last 3 months is 4,550,056 and the stock's 52-week low/high is $0.014/$0.1189.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Marijuana Company of America, Inc. (OTC: MCOA), a client of CNW that focuses on product research and development of legal hemp-based consumer products containing CBD under the brand name "hempSMART", an affiliate marketing program to promote and sell its products, as well as leasing of real property and expansion of business into ancillary areas of the legalized cannabis and hemp industry. Also today, the company was highlighted in an article examining how the Senate passed the 2018 Farm Bill on December 11, 2018, and on December 12, 2018, the House followed suit. This could be a significant legislative package that reauthorizes agriculture programs and food aid; more specifically for marijuana stocks, it also legalizes hemp and in turn, hemp-based CBD, which is widely used for both recreational and medical purposes.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.02782, up 1.16%, on 70,038,137 volume with 2,192 trades. The average volume for the last 3 months is 8,720,863 and the stock's 52-week low/high is $0.0115/$0.0728.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions, Inc. (OTC: DVLP), a rising leader in the cannabis industry, provides its clients with business services and products to support the flourishing market. Through its ancillary software, the company seeks to connect members of the cannabis community by increasing the ease of connection between growers, distributors and both medical and recreational users.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.0199, off by 9.13%, on 149,124 volume with 18 trades. The average volume for the last 3 months is 665,382 and the stock's 52-week low/high is $0.0125/$0.14.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions, recently named Dr. Bradford A. Young as its senior vice president and chief commercial officer. To view the full article, visit: http://nnw.fm/YeRW5.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $1.85, off by 2.63%, on 6,708 volume with 10 trades. The average volume for the last 3 months is 4,174 and the stock's 52-week low/high is $1.77/$5.00.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $3.35, up 8.41%, on 196,760 volume with 154 trades. The average volume for the last 3 months is 105,345 and the stock's 52-week low/high is $2.74/$8.00.

Recent News

chart

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.01955, up 8.61%, on 91,325 volume with 27 trades. The average volume for the last 3 months is 401,544 and the stock's 52-week low/high is $0.0127/$0.092.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.